Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about COMPOUND 1F: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | COMPOUND 1F |
graph TD
COMPOUND_1F[COMPOUND 1F]
COMPOUND_1F -->|activates| Tnf___Nf__b_Mapk_Signaling_Pat[Tnf-Α/Nf-Κb/Mapk Signaling Pathway]
COMPOUND_1F -->|suppresses| Glioblastoma[Glioblastoma]
COMPOUND_1F -->|activates| TNF___NF__B_MAPK_signaling_pat[TNF-α/NF-κB/MAPK signaling pathway]
COMPOUND_1F -->|inhibits| glioblastoma_cell_proliferatio[glioblastoma cell proliferation]
COMPOUND_1F -->|inhibits| orthotopic_glioblastoma_growth[orthotopic glioblastoma growth]
COMPOUND_1F -.protects against.-> Drug_Resistance[Drug Resistance]
COMPOUND_1F -->|activates| TNF___NF__B_MAPK[TNF-α/NF-κB/MAPK]| Target | Relation | Type | Str |
|---|---|---|---|
| Apoptosis | associated_with | process | 0.95 |
| Glioblastoma | suppresses | disease | 0.95 |
| Necroptosis | associated_with | process | 0.95 |
| Tnf-Α/Nf-Κb/Mapk Signaling Pathway | activates | pathway | 0.95 |
| necroptosis | associated_with | process | 0.95 |
| TNF-α/NF-κB/MAPK signaling pathway | activates | pathway | 0.90 |
| glioblastoma cell proliferation | inhibits | phenotype | 0.90 |
| mitochondria-dependent apoptosis | associated_with | process | 0.90 |
| Blood-Brain Barrier Permeability | associated_with | phenotype | 0.90 |
| Glioblastoma | treats | disease | 0.85 |
| orthotopic glioblastoma growth | inhibits | phenotype | 0.85 |
| Glioblastoma | treats | disease | 0.85 |
| Drug Resistance | protects_against | phenotype | 0.85 |
| blood-brain barrier | associated_with | brain_region | 0.80 |
| glioblastoma survival rate | associated_with | phenotype | 0.80 |
| TNF-α/NF-κB/MAPK | activates | compound | 0.70 |
| Source | Relation | Type | Str |
|---|---|---|---|
| No incoming edges | |||
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning COMPOUND 1F in their description or question text
No additional research found